What are the macrophages and stellate cells doing in pancreatic adenocarcinoma?

Stephen J Pandol1, Mouad Edderkaoui1

  • 1Departments of Medicine and Biological Sciences, Cedars-Sinai Medical Center Los Angeles, CA, USA ; Veterans Affairs Greater Los Angeles Healthcare System and University of California, Los Angeles Los Angeles, CA, USA.

Insights

Pancreatic cancer

Area of Science:

  • Oncology
  • Cancer Biology
  • Tumor Microenvironment

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) is marked by a dense desmoplastic stroma.
  • Conventional therapies targeting cancer cells show limited efficacy, indicating the stroma's role in treatment resistance.
  • Tumor stroma components influence cancer cell proliferation, apoptosis resistance, epithelial-to-mesenchymal transition (EMT), and stemness.

Purpose of the Study:

  • To review current findings on the dual role of pancreatic stellate cells and macrophages in pancreatic cancer.
  • To focus on how these stromal cells affect EMT and cancer stemness in PDAC.

Main Methods:

  • Literature review of recent studies on pancreatic cancer stroma.
  • Analysis of the roles of pancreatic stellate cells and macrophages.
  • Examination of their impact on epithelial-to-mesenchymal transition and cancer stemness.

Main Results:

  • Pancreatic stellate cells and macrophages can promote or inhibit pancreatic cancer progression.
  • These stromal cells significantly influence cancer cell EMT and stemness.
  • Emerging evidence suggests potential protective roles for activated stellate cells.

Conclusions:

  • Stromal cells, particularly pancreatic stellate cells and macrophages, are critical regulators in pancreatic cancer.
  • Understanding their complex roles in EMT and stemness is vital for developing effective therapeutic strategies.
  • Further research into the context-dependent functions of these stromal cells may reveal new treatment avenues.